Cargando…
The broad spectrum host-directed agent ivermectin as an antiviral for SARS-CoV-2 ?
FDA approved for parasitic indications, the small molecule ivermectin has been the focus of growing attention in the last 8 years due to its potential as an antiviral. We first identified ivermectin in a high throughput compound library screen as an agent potently able to inhibit recognition of the...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577703/ https://www.ncbi.nlm.nih.gov/pubmed/33341233 http://dx.doi.org/10.1016/j.bbrc.2020.10.042 |